Literature DB >> 2552485

Lack of effects of 5HT3 receptor antagonists in the social interaction and elevated plus-maze tests of anxiety in the rat.

S E File1, A L Johnston.   

Abstract

The effects of three 5HT3 receptor antagonists: BRL 43964 (0.1 and 1 mg/kg, oral), GR 38032F (0.1 and 1 mg/kg, oral), and zacopride (0.01, 0.1 and 1 mg/kg, IP) were examined in low light test conditions of the social interaction test. None of the three 5HT3 receptor antagonists had a significant effect on social interaction. In contrast, in two experiments chlordiazepoxide (7.5 mg/kg) significantly increased social interaction and this effect was greatest in the unfamiliar test condition. In a third experiment, the effects of GR 38032F (0.1 and 1 mg/kg, oral) and zacopride (0.01, 0.1 and 1 mg/kg, oral) were investigated in the high light test conditions of the social interaction test; neither compound had a significant effect. In the elevated plus-maze, chlordiazepoxide (7.5 mg/kg oral or IP) significantly increased both the per cent number of entries made onto open arms and the per cent of time spent on the open arms, indicating an anxiolytic action. Zacopride (0.01, 0.1 and 1 mg/kg, oral or IP) had no significant effect in this test. The effect of the baseline rate of responding in the social interaction test on the effects of 5-HT3 antagonists is discussed. The results from the present experiment and those from other animal tests of anxiety caution against the conclusion that 5HT3 receptor antagonists are anxiolytic.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2552485     DOI: 10.1007/BF00442817

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  8 in total

1.  Comparison of drug effects on responding punished by pressurized air or electric shock delivery in squirrel monkeys: pentobarbital, chlordiazepoxide, d-amphetamine and cocaine.

Authors:  R D Spealman
Journal:  J Pharmacol Exp Ther       Date:  1979-05       Impact factor: 4.030

2.  Zacopride, a potent 5-HT3 antagonist.

Authors:  W W Smith; L F Sancilio; J B Owera-Atepo; R J Naylor; L Lambert
Journal:  J Pharm Pharmacol       Date:  1988-04       Impact factor: 3.765

3.  Zacopride: anxiolytic profile in rodent and primate models of anxiety.

Authors:  B Costall; A M Domeney; P A Gerrard; M E Kelly; R J Naylor
Journal:  J Pharm Pharmacol       Date:  1988-04       Impact factor: 3.765

Review 4.  The contribution of behavioural studies to the neuropharmacology of anxiety.

Authors:  S E File
Journal:  Neuropharmacology       Date:  1987-07       Impact factor: 5.250

5.  The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.

Authors:  B J Jones; B Costall; A M Domeney; M E Kelly; R J Naylor; N R Oakley; M B Tyers
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

6.  Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

Authors:  S Pellow; P Chopin; S E File; M Briley
Journal:  J Neurosci Methods       Date:  1985-08       Impact factor: 2.390

7.  Pharmacological characterisation of a modified social interaction model of anxiety in the rat.

Authors:  A P Guy; C R Gardner
Journal:  Neuropsychobiology       Date:  1985       Impact factor: 2.328

8.  Can social interaction be used to measure anxiety?

Authors:  S E File; J R Hyde
Journal:  Br J Pharmacol       Date:  1978-01       Impact factor: 8.739

  8 in total
  16 in total

Review 1.  Toward an integrative understanding of social phobia.

Authors:  D Li; P Chokka; P Tibbo
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Evidence that the amygdala is involved in the disinhibitory effects of 5-HT3 receptor antagonists.

Authors:  G A Higgins; B J Jones; N R Oakley; M B Tyers
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 3.  The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.

Authors:  A J Greenshaw; P H Silverstone
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

4.  GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus maze procedures.

Authors:  R Corbett; S Fielding; M Cornfeldt; R W Dunn
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 5.  Aggression, anxiety and vocalizations in animals: GABAA and 5-HT anxiolytics.

Authors:  K A Miczek; E M Weerts; J A Vivian; H M Barros
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

6.  Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze.

Authors:  E Vasar; E Peuranen; T Oöpik; J Harro; P T Männistö
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Differential profile of the CCKB receptor antagonist CI-988 and diazepam in the four-plate test.

Authors:  D J Dooley; I Klamt
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron.

Authors:  J L Muir; B J Everitt; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

9.  Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze.

Authors:  I K Wright; M Heaton; N Upton; C A Marsden
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Are there changes in sensitivity to 5-HT3 receptor ligands following chronic diazepam treatment?

Authors:  N Andrews; S E File
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.